Cargando…

Prognosis and risk factors of ERCP pancreatitis in elderly

Post Endoscopic Retrograde Cholangiopancreatography (ERCP) pancreatitis is one of the most serious complications of ERCP. Our study aims to investigate the risk, predisposing factors and prognosis of pancreatitis after ERCP in elderly patients. Patients referred to the ERCP unit between April 2008 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ergin, Erhan, Oruç, Nevin, Ersöz, Galip, Tekeşin, Oktay, Özütemiz, Ömer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342449/
https://www.ncbi.nlm.nih.gov/pubmed/34354184
http://dx.doi.org/10.1038/s41598-021-95484-8
_version_ 1783734072935186432
author Ergin, Erhan
Oruç, Nevin
Ersöz, Galip
Tekeşin, Oktay
Özütemiz, Ömer
author_facet Ergin, Erhan
Oruç, Nevin
Ersöz, Galip
Tekeşin, Oktay
Özütemiz, Ömer
author_sort Ergin, Erhan
collection PubMed
description Post Endoscopic Retrograde Cholangiopancreatography (ERCP) pancreatitis is one of the most serious complications of ERCP. Our study aims to investigate the risk, predisposing factors and prognosis of pancreatitis after ERCP in elderly patients. Patients referred to the ERCP unit between April 2008 and 2012 and admitted to the hospital at least 1 day after the ERCP procedure were included to the study. Information including patient’s demographics, diagnosis, imaging findings, biochemical analysis, details of the ERCP procedure and complications were recorded. The severity of post ERCP pancreatitis (PEP) was determined by revised Atlanta Criteria as well as APACHE II and Ranson scores. A total of 2902 ERCP patients were evaluated and 988 were included to the study. Patients were divided into two groups as ≥ 65 years old (494 patients, 259 F, 235 M) and < 65 years old (494 patients, 274 F, 220 M). PEP was diagnosed in 4.3% of patients aged 65 years and older. The female gender was risk factors in elderly for PEP. The Sphincter Oddi Dysfunction (SOD) and Juxta papillary diverticula (JPD) were higher in elderly patients with PEP. Age did not increase the risk of PEP development. The most important post ERCP pancreatitis risk factor in the elderly is the female gender, while the risk is enhanced slightly by SOD and JPD.
format Online
Article
Text
id pubmed-8342449
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83424492021-08-06 Prognosis and risk factors of ERCP pancreatitis in elderly Ergin, Erhan Oruç, Nevin Ersöz, Galip Tekeşin, Oktay Özütemiz, Ömer Sci Rep Article Post Endoscopic Retrograde Cholangiopancreatography (ERCP) pancreatitis is one of the most serious complications of ERCP. Our study aims to investigate the risk, predisposing factors and prognosis of pancreatitis after ERCP in elderly patients. Patients referred to the ERCP unit between April 2008 and 2012 and admitted to the hospital at least 1 day after the ERCP procedure were included to the study. Information including patient’s demographics, diagnosis, imaging findings, biochemical analysis, details of the ERCP procedure and complications were recorded. The severity of post ERCP pancreatitis (PEP) was determined by revised Atlanta Criteria as well as APACHE II and Ranson scores. A total of 2902 ERCP patients were evaluated and 988 were included to the study. Patients were divided into two groups as ≥ 65 years old (494 patients, 259 F, 235 M) and < 65 years old (494 patients, 274 F, 220 M). PEP was diagnosed in 4.3% of patients aged 65 years and older. The female gender was risk factors in elderly for PEP. The Sphincter Oddi Dysfunction (SOD) and Juxta papillary diverticula (JPD) were higher in elderly patients with PEP. Age did not increase the risk of PEP development. The most important post ERCP pancreatitis risk factor in the elderly is the female gender, while the risk is enhanced slightly by SOD and JPD. Nature Publishing Group UK 2021-08-05 /pmc/articles/PMC8342449/ /pubmed/34354184 http://dx.doi.org/10.1038/s41598-021-95484-8 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ergin, Erhan
Oruç, Nevin
Ersöz, Galip
Tekeşin, Oktay
Özütemiz, Ömer
Prognosis and risk factors of ERCP pancreatitis in elderly
title Prognosis and risk factors of ERCP pancreatitis in elderly
title_full Prognosis and risk factors of ERCP pancreatitis in elderly
title_fullStr Prognosis and risk factors of ERCP pancreatitis in elderly
title_full_unstemmed Prognosis and risk factors of ERCP pancreatitis in elderly
title_short Prognosis and risk factors of ERCP pancreatitis in elderly
title_sort prognosis and risk factors of ercp pancreatitis in elderly
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342449/
https://www.ncbi.nlm.nih.gov/pubmed/34354184
http://dx.doi.org/10.1038/s41598-021-95484-8
work_keys_str_mv AT erginerhan prognosisandriskfactorsofercppancreatitisinelderly
AT orucnevin prognosisandriskfactorsofercppancreatitisinelderly
AT ersozgalip prognosisandriskfactorsofercppancreatitisinelderly
AT tekesinoktay prognosisandriskfactorsofercppancreatitisinelderly
AT ozutemizomer prognosisandriskfactorsofercppancreatitisinelderly